Huons Global Co., Ltd. (084110.KQ)
KRW 46750.0
(-0.53%)
KRW 46750.0
(-0.53%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 294.87 Billion KRW | 8.83% |
| 2022 | 274.17 Billion KRW | 12.91% |
| 2021 | 242.82 Billion KRW | 21.98% |
| 2020 | 199.06 Billion KRW | 10.24% |
| 2019 | 180.56 Billion KRW | 17.11% |
| 2018 | 154.18 Billion KRW | 15.88% |
| 2017 | 133.05 Billion KRW | 125.05% |
| 2016 | 59.12 Billion KRW | 266.25% |
| 2015 | 16.14 Billion KRW | -74.78% |
| 2014 | 64.01 Billion KRW | 22.91% |
| 2013 | 52.08 Billion KRW | 2.61% |
| 2012 | 50.75 Billion KRW | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 84.64 Billion KRW | 5.34% |
| 2024 Q1 | 79.68 Billion KRW | -3.99% |
| 2023 FY | 298.38 Billion KRW | 8.83% |
| 2023 Q1 | 71.97 Billion KRW | 8.71% |
| 2023 Q4 | 82.99 Billion KRW | 13.79% |
| 2023 Q2 | 72.42 Billion KRW | 0.63% |
| 2023 Q3 | 72.93 Billion KRW | 0.7% |
| 2022 Q4 | 66.2 Billion KRW | -6.11% |
| 2022 Q1 | 65.86 Billion KRW | -2.56% |
| 2022 FY | 274.17 Billion KRW | 12.91% |
| 2022 Q2 | 69.73 Billion KRW | 5.88% |
| 2022 Q3 | 70.51 Billion KRW | 1.12% |
| 2021 Q1 | 52.59 Billion KRW | 50.35% |
| 2021 Q2 | 62.76 Billion KRW | 19.33% |
| 2021 Q3 | 60.5 Billion KRW | -3.59% |
| 2021 Q4 | 67.59 Billion KRW | 11.71% |
| 2021 FY | 242.82 Billion KRW | 21.98% |
| 2020 Q2 | 47.47 Billion KRW | 2.13% |
| 2020 Q3 | 48.52 Billion KRW | 2.23% |
| 2020 Q4 | 34.98 Billion KRW | -27.91% |
| 2020 Q1 | 46.48 Billion KRW | -14.69% |
| 2020 FY | 199.06 Billion KRW | 10.24% |
| 2019 Q4 | 54.48 Billion KRW | 20.8% |
| 2019 Q3 | 45.1 Billion KRW | 1.98% |
| 2019 Q2 | 44.22 Billion KRW | 8.83% |
| 2019 Q1 | 40.63 Billion KRW | -7.83% |
| 2019 FY | 180.56 Billion KRW | 17.11% |
| 2018 FY | 154.18 Billion KRW | 15.88% |
| 2018 Q4 | 44.09 Billion KRW | 34.91% |
| 2018 Q3 | 32.68 Billion KRW | -6.9% |
| 2018 Q2 | 35.1 Billion KRW | 4.95% |
| 2018 Q1 | 33.44 Billion KRW | -2.93% |
| 2017 Q4 | 34.45 Billion KRW | 10.18% |
| 2017 Q1 | 31.31 Billion KRW | -9.19% |
| 2017 Q2 | 32.06 Billion KRW | 2.41% |
| 2017 Q3 | 31.27 Billion KRW | -2.47% |
| 2017 FY | 133.05 Billion KRW | 125.05% |
| 2016 Q2 | 5.35 Billion KRW | 37.77% |
| 2016 Q4 | 34.47 Billion KRW | 80.91% |
| 2016 Q3 | 19.05 Billion KRW | 255.63% |
| 2016 Q1 | 3.89 Billion KRW | -27.98% |
| 2016 FY | 59.12 Billion KRW | 266.25% |
| 2015 Q2 | 4.22 Billion KRW | 32.11% |
| 2015 Q4 | 5.4 Billion KRW | 85.34% |
| 2015 Q3 | 2.91 Billion KRW | -30.96% |
| 2015 FY | 16.14 Billion KRW | -74.78% |
| 2015 Q1 | 3.19 Billion KRW | -83.64% |
| 2014 Q3 | 15.87 Billion KRW | 6.51% |
| 2014 Q1 | 13.7 Billion KRW | -18.89% |
| 2014 Q2 | 14.9 Billion KRW | 8.78% |
| 2014 Q4 | 19.52 Billion KRW | 22.99% |
| 2014 FY | 64.01 Billion KRW | 22.91% |
| 2013 Q2 | 14.13 Billion KRW | 38.78% |
| 2013 FY | 52.08 Billion KRW | 2.61% |
| 2013 Q1 | 10.18 Billion KRW | -24.79% |
| 2013 Q3 | 10.85 Billion KRW | -23.19% |
| 2013 Q4 | 16.89 Billion KRW | 55.58% |
| 2012 FY | 50.75 Billion KRW | 0.0% |
| 2012 Q4 | 13.54 Billion KRW | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| HLB Pharmaceutical Co., Ltd | 102.52 Billion KRW | -187.61% |
| CMG Pharmaceutical Co., Ltd. | 37.86 Billion KRW | -678.733% |
| Celltrion Pharm, Inc. | 80.93 Billion KRW | -264.334% |
| DongKook Pharmaceutical Co., Ltd. | 338.16 Billion KRW | 12.801% |
| Enzychem Lifesciences Corporation | 18.7 Billion KRW | -1476.532% |
| Humedix Co., Ltd. | 33.04 Billion KRW | -792.395% |
| Boditech Med Inc. | 47.05 Billion KRW | -526.709% |
| EuBiologics Co., Ltd. | 24.95 Billion KRW | -1081.407% |
| FutureChem Co.,Ltd | 9.16 Billion KRW | -3117.037% |
| Huons Co., Ltd. | 226.14 Billion KRW | -30.394% |
| BNC Korea Co., Ltd. | 25.19 Billion KRW | -1070.203% |
| AptaBio Therapeutics Inc. | 16.45 Billion KRW | -1692.357% |